Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04629209
Title A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Oncoceutics, Inc.
Indications

glioblastoma

Therapies

ONC201

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST